| 标题 |
 375P Surufatinib (S) in combination with camrelizumab (C), nab-paclitaxel and gemcitabine (AG) as the first-line treatment in metastatic pancreatic cancer: Results from phase II part of a randomized, open-label, active-controlled, phase II/III study |
| 网址 | |
| DOI | |
| 其它 |
期刊：Annals of Oncology 作者：S. Qin; J. Hao; C. Xun; Y. Zhang; B. Shen; et al 出版日期：2025-12-23 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
null
忧心的曼凝
嘻嘻哈哈
Maestro_S
吃葡萄不吐葡萄皮
学霸业
GingerF
369ninja
Criminology34
秋风
OK
Nole
pluto
牧青
无极微光
风吹麦浪
v0id
sissiarno
云曦
追风少年
皖公网安备34019202002308
